Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_3
2
29%
Ph not_applicable
3
43%
Ph phase_2
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (28.6%)
Phase 32 (28.6%)
N/A3 (42.9%)

Trials by Status

terminated114%
unknown229%
completed457%

Recent Activity

0 active trials
Showing 5 of 7
completednot_applicable

Dose Escalation Versus Standard in Laryngopharyngeal Cancers

NCT02757222
terminatedphase_3

High-dose Vitamin D3 in Pancreas Cancer

NCT03472833
unknownphase_2

Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy 

NCT04933357
completednot_applicable

Comparison of Contrast Agent Administration Protocols

NCT04300972
completednot_applicable

Fathers and Late Preterm Babies Study

NCT01056653
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02757222Not Applicable

Dose Escalation Versus Standard in Laryngopharyngeal Cancers

Completed
NCT03472833Phase 3

High-dose Vitamin D3 in Pancreas Cancer

Terminated
NCT04933357Phase 2

Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy 

Unknown
NCT04300972Not Applicable

Comparison of Contrast Agent Administration Protocols

Completed
NCT01056653Not Applicable

Fathers and Late Preterm Babies Study

Completed
NCT02797145Phase 2

Intensive Versus Conventional Digoxin Use in Patients With Heart Failure

Unknown
NCT01812486Phase 3

Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer

Completed

All 7 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
7